Newsroom

Actions

141010 PR FR VI Orsiro EN

Actions

BIOTRONIK to Offer New Treatment Options in France with Release of Orsiro Drug-Eluting Stent

Launch of Industry’s First Hybrid DES System Marks Expansion of the Proven Hybrid Model to Treat a Wider Range of Lesions






Please contact us if you require further information

${loading}